Novartis (NVS)

Add to Watchlists Create an Alert
74.35 +0.53  +0.72%   NYSE May 24, 5:00PM BATS Real time Currency in USD

Novartis Debt to Equity Ratio:

0.3125 for March 31, 2013
View Full Chart

Novartis Debt to Equity Ratio Chart

    Novartis Historical Debt to Equity Ratio Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 0.3125
    Dec. 31, 2012 0.2855
    Sept. 30, 2012 0.3107
    June 30, 2012 0.3529
    March 31, 2012 0.3897
    Dec. 31, 2011 0.3072
    Sept. 30, 2011 0.3612
    June 30, 2011 0.41
    March 31, 2011 0.4762
    Dec. 31, 2010 0.363
    Sept. 30, 2010 0.4072
    June 30, 2010 0.334
    March 31, 2010 0.3247
    Dec. 31, 2009 0.2437
    Sept. 30, 2009 0.2695
    June 30, 2009 0.2747
    March 31, 2009 0.2477
    Dec. 31, 2008 0.1464
    Sept. 30, 2008 0.2129
    June 30, 2008 0.2079
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Debt to Equity Ratio

    Leverage ratio indicating the relative proportion of shareholders' equity and debt used to finance a company's assets. A low debt to equity ratio indicates lower risk, because debt holders have less claims on the company's assets. A debt to equity ratio of 5 means that debt holders have a 5 times more claim on assets than equity holders.

    A high debt to equity ratio usually means that a company has been aggressive in financing growth with debt and often results in volatile earnings.

    It is also known as Debt/Equity Ratio, Debt-Equity Ratio, and D/E Ratio.
    Learn More

    Get data for

    NVS Debt to Equity Ratio Benchmarks

    Companies
    Sanofi
    Pfizer 0.4909
    GlaxoSmithKline 2.886

    NVS Debt to Equity Ratio Rankings

    Overall 68th percentile
    2519 of 8009
    Sector 47th percentile
    360 of 687 in Healthcare
    Industry 52nd percentile
    26 of 55 in Drug Manufacturers - Major

    NVS Debt to Equity Ratio Range, Past 5 Years

    Minimum 0.1464 Dec 2008
    Maximum 0.4762 Mar 2011
    Average 0.3119